Innovative Medicines and Medical Technology Review

Department of Health written question – answered on 13th November 2017.

Alert me about debates like this

Photo of Jim Shannon Jim Shannon Shadow DUP Spokesperson (Human Rights), Shadow DUP Spokesperson (Health)

To ask the Secretary of State for Health, what discussions he has had with the pharmaceutical industry on the cost effectiveness criteria for new treatments seeking breakthrough designation through the Accelerated Access Pathway.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary of State for Health

Ministers and officials from the Department meet regularly with the pharmaceutical industry to discuss policy development and implementation. Engagement will continue on the implementation of the Accelerated Access pathway and criteria for breakthrough products.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.